Core Viewpoint - BioNexus Gene Lab Corp. has filed a registration statement with the SEC to register up to $100 million of securities, aiming to enhance financial flexibility and support growth initiatives in precision diagnostics and gene-based technologies [1][3][4] Group 1: Financial Strategy - The company has entered into an Equity Distribution Agreement with Maxim Group LLC, allowing it to offer and sell up to $20 million of its common stock through an at-the-market (ATM) program [2] - The shelf registration and ATM facility are expected to provide structural capital readiness to support the execution of growth and operating initiatives [4] Group 2: Growth Initiatives - BioNexus is focusing on expanding its footprint in precision oncology, regenerative medicine, and contract biologics manufacturing through its subsidiaries MRNA Scientific Sdn. Bhd. and Chemrex Corporation Sdn. Bhd. [3][6] - Recent partnerships with Fidelion Diagnostics Pte Ltd. and BirchBioMed Inc. are part of the company's strategy to drive growth [3] Group 3: Market Positioning - The company aims to transform into a next-generation biotechnology platform serving both Asian and U.S. markets [4] - BioNexus is building a platform that spans precision medicine, biologics manufacturing, and AI-integrated healthcare solutions [6]

Core Insights - Ocumetics Technology Corp. is participating in the 2025 Maxim Growth Summit, highlighting its role as a leader in advanced ophthalmic technology [1][2] - The company is currently in the early feasibility study phase for a revolutionary intraocular lens designed to provide clear vision at all distances without corrective lenses [5] Company Overview - Ocumetics Technology Corp. is a Canadian research and product development company focused on advanced vision correction solutions aimed at enhancing patients' quality of life [4] - The company is dedicated to transforming ophthalmology through innovative research and development of state-of-the-art intraocular lenses and other vision-enhancing technologies [4] Event Participation - Dean Burns, President and CEO of Ocumetics, will participate in a panel titled 'A vision of Innovation' at the Maxim Growth Summit [2] - The summit will feature keynote speakers and roundtable discussions covering various topics, including biotechnology and ophthalmology [3] Technology Development - Ocumetics is developing an intraocular lens that fits within the natural lens compartment of the eye, potentially eliminating the need for glasses or contact lenses [5] - The lens is designed to utilize the eye's natural muscle activity to shift focus, providing clear vision at all distances [5]

Core Points - AIM ImmunoTech Inc. will participate in the 2025 Maxim Growth Summit on October 22-23, 2025, in New York, NY, which focuses on industry trends and advancements [1] - Management will be available for in-person one-on-one meetings with registered investors during the conference [2] - AIM ImmunoTech is an immuno-pharma company developing therapeutics for cancers, immune disorders, and viral diseases, with its lead product being Ampligen, currently in Phase 2 clinical trials for metastatic pancreatic cancer in collaboration with AstraZeneca [4] Company Information - AIM ImmunoTech Inc. specializes in research and development of therapeutics targeting multiple diseases, including COVID-19 [4] - The company's lead product, Ampligen (rintatolimod), is a first-in-class investigational drug that acts as a dsRNA and TLR3 agonist [4] - AIM ImmunoTech is focused on broad-spectrum activity in clinical trials, particularly in combination therapies for cancer treatment [4] Event Information - The Maxim Growth Summit is organized by Maxim Group LLC, a full-service investment banking and wealth management firm based in New York [3] - The summit will feature industry leaders and innovators discussing the latest trends across various sectors [1] - For more details on the summit agenda and AIM's presentation, interested parties can visit the respective websites [2]

Core Insights - Castellum, Inc. is participating in the 2025 Maxim Growth Summit, scheduled for October 22nd to 23rd at The Hard Rock Hotel NYC, focusing on cybersecurity, electronic warfare, and software engineering services for the federal government [1][4]. Company Participation - Castellum will engage in one-on-one sessions with institutional investors and senior analysts from Maxim during the summit [2]. - The event will feature keynote speakers such as Larry Kudlow and Christopher Ruddy, along with roundtable discussions involving CEOs from various sectors including biotechnology, artificial intelligence, and energy [2]. Event Details - The Maxim Growth Summit aims to explore the latest trends and advancements across multiple industries, providing a platform for networking and discussions among industry leaders and innovators [1][2].

Core Insights - Volatus Aerospace Inc. is participating in the 2025 Maxim Growth Summit, highlighting its role as a leader in aerial intelligence and unmanned aircraft systems [1] - The event will feature one-on-one meetings between Volatus executives and institutional investors, indicating a focus on investor relations and potential funding opportunities [2] - Keynote speakers and roundtable discussions at the summit will cover various sectors, including drones, which aligns with Volatus's business focus [3] Company Overview - Volatus Aerospace Inc. specializes in aerial solutions for intelligence, surveillance, and cargo, utilizing both piloted and remotely piloted aircraft [6] - The company offers a comprehensive ecosystem of aerial services, including operations, equipment sales, training, and mission support, aimed at integrating aerial capabilities into various industries [6] Event Details - The 2025 Maxim Growth Summit will take place from October 22nd to 23rd at The Hard Rock Hotel NYC, bringing together industry leaders and innovators [1] - The conference will include discussions on advancements in multiple sectors, showcasing the relevance of aerial technology in contemporary industry trends [3]

Core Insights - DeFi Technologies Inc. is participating in the 2025 Maxim Growth Summit, scheduled for October 22-23 at The Hard Rock Hotel NYC, focusing on trends in decentralized finance and traditional capital markets [1][2]. Company Overview - DeFi Technologies is a financial technology company that connects traditional capital markets with decentralized finance (DeFi), being the first Nasdaq-listed digital asset manager [7][8]. - The company offers diversified exposure to the decentralized economy through various subsidiaries, including Valour, Stillman Digital, Reflexivity Research, Neuronomics, and DeFi Alpha [7][8]. Event Participation - The 2025 Maxim Growth Summit will feature keynote speakers such as Larry Kudlow and Christopher Ruddy, along with roundtable discussions covering sectors like biotechnology, artificial intelligence, and energy [2]. - DeFi Technologies will engage in one-on-one meetings with institutional investors and analysts during the summit [1]. Upcoming Conferences - DeFi Technologies has a schedule of upcoming conferences, including: - Cantor Crypto, AI/Energy Infrastructure Conference on November 10-12 in Miami - Benchmark 14th Annual Discovery One-on-One Investor Conference on December 4 in NYC - Northland Virtual Growth Conference on December 16 [6].

Company Overview - HCW Biologics Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies targeting chronic inflammation and associated diseases [5] - The company's lead product candidate, HCW9302, was developed using the TOBI™ platform, and it has also created the TRBC platform for constructing immunotherapeutics [5] - The TRBC platform enables the development of multiple classes of immunotherapeutic compounds, including multi-functional immune cell stimulators and second-generation immune checkpoint inhibitors [5] Upcoming Event - HCW Biologics will participate in the 2025 Maxim Growth Summit on October 22nd to 23rd at The Hard Rock Hotel NYC, which gathers industry leaders and innovators [1] - Dr. Hing C. Wong, the CEO, will meet with institutional investors and senior analysts during the event [2] - Keynote speakers at the summit include Larry Kudlow and Christopher Ruddy, with discussions covering various sectors including biotechnology and artificial intelligence [3] Company Pipeline - The company has constructed over 50 molecules using the TRBC platform, with ongoing preclinical evaluation studies based on promising data [5] - HCW Biologics has two licensing programs for exclusive rights to some proprietary molecules [5] Maxim Group Overview - Maxim Group LLC is a full-service investment banking and wealth management firm providing a range of financial services [6] - The firm is registered with the U.S. Securities and Exchange Commission and is a member of FINRA, SIPC, and NASDAQ [6]

Core Insights - Autonomix Medical, Inc. will participate in the 2025 Maxim Growth Summit on October 22-23, 2025, in New York, showcasing its commitment to advancing precision nerve-targeted treatments [1][2] Company Overview - Autonomix is a medical device company focused on innovative technologies for diagnosing and treating diseases of the nervous system [4] - The company's first-in-class platform includes a catheter-based microchip sensing array designed to detect and differentiate neural signals with greater sensitivity than existing technologies [4] - The technology aims to enable transvascular diagnosis and treatment of peripheral nervous system diseases throughout the body [4] Technology Development - Initial development of the technology targets pain management, specifically for pancreatic cancer, which is known for causing severe pain and lacks reliable treatment options [5] - The technology serves as a platform for addressing various indications, including cardiology, hypertension, and chronic pain management [5] - The technology is currently investigational and has not yet received marketing clearance in the United States [5]

Core Insights - AmpliTech Group, Inc. will participate in the 2025 Maxim Growth Summit, scheduled for October 22-23, 2025, at The Hard Rock Hotel NYC [1] - The event will feature one-on-one meetings with institutional investors and senior analysts from Maxim, focusing on industry trends and advancements [2] Company Overview - AmpliTech Group is a designer and manufacturer of advanced signal-processing components for satellite, Public and Private 5G, and other communications networks, including complete 5G/6G systems [1][5] - The company operates five divisions, including AmpliTech Inc. and Specialty Microwave, and serves global markets such as telecommunications, space exploration, and defense [5] Event Details - The Maxim Growth Summit will include keynote speakers like Larry Kudlow and Christopher Ruddy, along with roundtable discussions featuring CEOs from small and mid-cap companies across various sectors [2] - Topics of discussion will encompass biotechnology, artificial intelligence, energy, and more, highlighting the event's focus on innovation and industry leadership [2]

Core Insights - AmpliTech Group, Inc. is participating in the 2025 Maxim Growth Summit, scheduled for October 22nd to 23rd at The Hard Rock Hotel NYC, focusing on advanced signal-processing components for communications networks [1][2] Company Overview - AmpliTech Group is a designer and manufacturer of advanced RF microwave components and 5G network solutions, serving markets such as satellite communications, telecommunications, space exploration, defense, and quantum computing [4] - The company operates through five divisions: AmpliTech Inc., Specialty Microwave, Spectrum Semiconductors Materials, AmpliTech Group Microwave Design Center, and AmpliTech Group True G Speed Services [4] Event Details - The Maxim Growth Summit will feature one-on-one meetings between AmpliTech Group and institutional investors, as well as discussions with senior analysts [2] - Keynote speakers at the event include Larry Kudlow and Christopher Ruddy, with roundtable discussions covering various sectors such as biotechnology, artificial intelligence, and energy [2]